Skip to search formSkip to main contentSkip to account menu

Shigella Vaccines

Known as: Shigella Vaccines [Chemical/Ingredient], Shigella vaccine, Vaccines, Shigella 
Vaccines or candidate vaccines used to prevent bacillary dysentery (DYSENTERY, BACILLARY) caused by species of SHIGELLA.
National Institutes of Health

Related topics

Related topics

10 relations

Broader (1)

Bacterial Vaccines
In BloodProcess of secretionShigella dysenteriaeagonists

Narrower (1)

WRSF2G11

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children.
Review
2013
Review
2013
Progress and pitfalls in Shigella vaccine research
Renewed awareness of the substantial morbidity and mortality that Shigella infection causes among young children in developing… 
Review
2006
Review
2006
Live-attenuated Shigella vaccines
Several live-attenuated Shigella vaccines, with well-defined mutations in specific genes, have shown great promise in eliciting… 
Highly Cited
2000
Highly Cited
2000
Attenuated Shigella flexneri 2a Vaccine Strain CVD 1204 Expressing Colonization Factor Antigen I and Mutant Heat-Labile Enterotoxin of Enterotoxigenic Escherichia coli
ABSTRACT A multivalent live oral vaccine against both Shigellaspp. and enterotoxigenic Escherichia coli (ETEC) is being developed… 
Highly Cited
1999
Highly Cited
1999
Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
An intranasal vaccine vector would elicit protective immunity at the respiratory mucosa, the portal of entry and the primary site… 
1999
1999
Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile.
BACKGROUND Shigella is an important cause of diarrheal disease in children in developing countries. The increasing prevalence of… 
Highly Cited
1996
Highly Cited
1996
Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic…
The use of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a live vector for enterotoxigenic Escherichia… 
Review
1995
Review
1995
Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Up to now, no effective vaccine is available against shigellosis, a dysenteric syndrome caused by Shigella, a Gram-negative… 
Review
1992
Review
1992
Bacterial enteric infections and vaccine development.
Highly Cited
1977
Highly Cited
1977
Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.
In an attempt to develop a safe, proliferating, oral, attenuated vaccine against shigellosis, genes that control the synthesis of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)